BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 14691184)

  • 1. Rod and cone photoreceptor function in patients with cone dystrophy.
    Holopigian K; Greenstein VC; Seiple W; Hood DC; Carr RE
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):275-81. PubMed ID: 14691184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for photoreceptor changes in patients with diabetic retinopathy.
    Holopigian K; Greenstein VC; Seiple W; Hood DC; Carr RE
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2355-65. PubMed ID: 9344359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic assessment of photoreceptor function in patients with primary open-angle glaucoma.
    Holopigian K; Greenstein VC; Seiple W; Hood DC; Ritch R
    J Glaucoma; 2000 Apr; 9(2):163-8. PubMed ID: 10782626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations Between Dark-Adapted Rod Threshold Elevations and ERG Response Deficits in Duchenne Muscular Dystrophy.
    Barboni MTS; Dias SL; Silva LA; Damico FM; Vidal KS; Costa MF; Nagy BV; Kremers J; Ventura DF
    Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):29. PubMed ID: 33891680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local cone and rod system function in progressive cone dystrophy.
    Holopigian K; Seiple W; Greenstein VC; Hood DC; Carr RE
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2364-73. PubMed ID: 12091439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinctive form of congenital stationary night blindness with cone ON-pathway dysfunction.
    Barnes CS; Alexander KR; Fishman GA
    Ophthalmology; 2002 Mar; 109(3):575-83. PubMed ID: 11874764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Methyl-N-Nitrosourea-Induced Acute Alteration of Retinal Function and Morphology in Monkeys.
    Kinoshita J; Iwata N; Maejima T; Imaoka M; Kimotsuki T; Yasuda M
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7146-58. PubMed ID: 26529049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.
    Roman AJ; Schwartz SB; Aleman TS; Cideciyan AV; Chico JD; Windsor EA; Gardner LM; Ying GS; Smilko EE; Maguire MG; Jacobson SG
    Exp Eye Res; 2005 Feb; 80(2):259-72. PubMed ID: 15670804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychophysical measurement of rod and cone thresholds in stargardt disease with full-field stimuli.
    Collison FT; Fishman GA; McAnany JJ; Zernant J; Allikmets R
    Retina; 2014 Sep; 34(9):1888-95. PubMed ID: 24695063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local cone and rod system function in patients with retinitis pigmentosa.
    Holopigian K; Seiple W; Greenstein VC; Hood DC; Carr RE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):779-88. PubMed ID: 11222541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rod and cone function in the Nougaret form of stationary night blindness.
    Sandberg MA; Pawlyk BS; Dan J; Arnaud B; Dryja TP; Berson EL
    Arch Ophthalmol; 1998 Jul; 116(7):867-72. PubMed ID: 9682699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rod sensitivity, cone sensitivity, and photoreceptor layer thickness in retinal degenerative diseases.
    Birch DG; Wen Y; Locke K; Hood DC
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7141-7. PubMed ID: 21810977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoreceptor and postreceptor responses in congenital stationary night blindness.
    Raghuram A; Hansen RM; Moskowitz A; Fulton AB
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4648-58. PubMed ID: 23761088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
    Birch DG; Anderson JL; Fish GE
    Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rod and cone dysfunction in carriers of X-linked retinitis pigmentosa.
    Peachey NS; Fishman GA; Derlacki DJ; Alexander KR
    Ophthalmology; 1988 May; 95(5):677-85. PubMed ID: 3174027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding changes in the b-wave of the ERG caused by heterogeneous receptor damage.
    Hood DC; Shady S; Birch DG
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2477-88. PubMed ID: 8163337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-color pupillometry in KCNV2 retinopathy.
    Collison FT; Park JC; Fishman GA; Stone EM; McAnany JJ
    Doc Ophthalmol; 2019 Aug; 139(1):11-20. PubMed ID: 30927187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full-field electroretinogram in autism spectrum disorder.
    Constable PA; Gaigg SB; Bowler DM; Jägle H; Thompson DA
    Doc Ophthalmol; 2016 Apr; 132(2):83-99. PubMed ID: 26868825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional changes in rod and cone pathways after photoreceptor loss in light-damaged rats.
    Takahashi T; Machida S; Masuda T; Mukaida Y; Tazawa Y
    Curr Eye Res; 2005 Aug; 30(8):703-13. PubMed ID: 16109651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of rod and cone pathways to the dark-adapted electroretinogram (ERG) b-wave following retinal degeneration in RCS rats.
    Pinilla I; Lund RD; Sauvé Y
    Vision Res; 2004; 44(21):2467-74. PubMed ID: 15358082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.